Blog Articles

Chromosomal aneuploidies are the most common cause of first-trimester miscarriage, accounting for approximately 50% of spontaneous abortions.

Newborn screening is a worldwide recognised public health measure aimed at the early screening, diagnosis and management of selected metabolic diseases.

Discover how pre-implantation genetic screening can reduce the risk of miscarriage and genetic conditions during IVF.

The first step in developing the most appropriate treatment plan for a patient with dry eye disease (DED) is to correctly categorise the stage and type of DED the patient exhibits using the available technology. Then address the patient’s symptoms using the appropriate evidence-based therapies.

We are at the cusp of a stem cell revolution. Understanding and harnessing these unique cells may unlock breakthroughs in longevity and therapeutic solutions to all kinds of chronic diseases and regenerative opportunities.

Stem cells are a type of cell that holds the potential to differentiate into different cell types and self-renew. The interest in stem cells in the medical field is at an all-time high. 

While a considerable amount of data exists for clinical trials and laboratory performance for non-invasive prenatal testing (NIPT) of autosomal aneuploidies (chromosomal abnormalities), relatively little data is available on laboratory performance for sex chromosome aneuploidies.

Exciting clinical work continues in transplant medicine and mesenchymal stem cell therapy. Recent studies from China highlight the co-transplantation of umbilical cord mesenchymal stem cells (UC-MSC) and umbilical cord blood haematopoietic stem cells (CB-HSC).

Next Biosciences’ role in developing FirstScreen with North-West University is to establish a newborn screening programme that is widely accessible to South African doctors and patients.

Act now to give your baby the best chance for a healthy future. Learn about newborn screening and how it can detect serious conditions early on.